P2RY12 and bacterial infectious disease with sepsis: This study aimed to evaluate the effects of P2Y12 inhibitor use before admission on microbiological clearance and clinical outcomes in Japanese patients with SAB, focusing on persistent bacteremia, mortality, and potential adverse events such as bleeding.